Sunday House Call, #666,  September 9, 2018: Cannabis marketing ads using observational in-house studies to bolster claims for use. Get back to me with real studies then we will talk.

Dr. Barry Dworkin

Sunday House Call, #666,  September 9, 2018: Cannabis marketing ads using observational in-house studies to bolster claims for use. Get back to me with real studies then we will talk.

Topics today include:

Some Cannabis companies are sponsoring their own studies to promote Cannabis as an alternative to pain medication. (National Post Saturday Sept 8, 2018, Page A7)  These observational studies are often biased and do not provide conclusive medical facts.

Your calls on Cannabis as a replacement for pain medication and claims of cancer treatment successes, complications from kidney stones, hypertension medication, efficacy of standard hospital masks.

[display_podcast]

Related posts:

  1. Sunday House Call #642,  February 18, 2018: Systematic review gives straight dope on medical use of cannabis. Let the Backfire-Effect-Games begin.
  2. Sunday House Call, #671,  October 14, 2018: Cannabidiol: Mainstream companies will market the hype, ignore the evidence, and the fail to acknowledge the unknown. Just look at the supplement industry.
  3. Sunday House Call, #704, July 29, 2019: CBD oil for pain? Not so fast. It may be the flavonoids! A post hoc ergo propter hoc adventure
  4. Sunday House Call, #753, August 23, 2020: Stop the old canards about #obesity and start treating it like the chronic disease it is by providing therapeutic support as outlined in the new Canadian management guidelines.